NYSEARCA:SBIO ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free SBIO Stock Alerts $34.47 -0.87 (-2.46%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$34.47▼$35.3350-Day Range$31.51▼$38.6952-Week Range$23.21▼$38.80Volume13,793 shsAverage Volume12,794 shsMarket Capitalization$119.61 millionAssets Under Management$114.76 millionDividend Yield0.00%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get ALPS Medical Breakthroughs ETF alerts: Email Address About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.Read More SBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBIO ETF News HeadlinesFebruary 22, 2024 | benzinga.comALPS ETF Trust ALPS Intermediate Municipal Bond ETF (ARCA:MNBD) Dividends: History, Yield and DatesFebruary 11, 2024 | msn.comI checked into a £40,000-a-week rehab in the Swiss AlpsMarch 18, 2024 | Porter & Company (Ad)My next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.January 19, 2024 | seekingalpha.comHow ETF Investors Can Take Advantage Of Deal ActivityDecember 30, 2023 | finance.yahoo.comBiotech ETF SBIO’s Momentum Strong to End 2023December 22, 2023 | msn.comALPS Medical Breakthroughs ETF declares annual distribution of $0.0711December 10, 2023 | finance.yahoo.comPlay US Gene Treatment Approval in SBIOSeptember 12, 2023 | finance.yahoo.comSBIO - ALPS Medical Breakthroughs ETFMarch 18, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.August 11, 2023 | benzinga.comALPS Medical Breakthroughs ETF (ARCA:SBIO), Quotes and News SummarySee More Headlines Receive SBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerALPS Fund NameALPS Medical Breakthroughs ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SBIO Inception Date12/31/2014 Fund ManagerRyan Mischker, Andrew Hicks WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS-Network Medical Breakthroughs Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings98 Fund Statistics Assets Under Management$114.76 million Average Daily Volume$9,172.30 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorALPS Fund Services, Inc. AdvisorALPS Advisors, Inc. CustodianState Street Bank and Trust Company DistributorALPS Portfolio Solutions Distributor, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerGTS Options OptionableOptionable Options Volume3 Put Options3 Call Options2 Short Interest16,400 shs Miscellaneous Outstanding Shares3,470,000Beta0.92 Creation Unit50,000 Creation Fee$500.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. ALPS Medical Breakthroughs ETF ExpensesTypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.50%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.50%0.72%0.70%0.73%0.70%Fee Waiver0.00%-0.53%-0.54%-0.68%-0.56%Net Expense0.50%0.61%0.60%0.57%0.58% ALPS Medical Breakthroughs ETF (SBIO) Holdings & ExposureTop 10 SBIO HoldingsAlkermes(NASDAQ:ALKS)Holding Weight: 3.30%Cerevel Therapeutics(NASDAQ:CERE)Holding Weight: 3.29%ACADIA Pharmaceuticals(NASDAQ:ACAD)Holding Weight: 3.25%Vaxcyte(NASDAQ:PCVX)Holding Weight: 3.01%Amicus Therapeutics(NASDAQ:FOLD)Holding Weight: 2.66%Denali Therapeutics(NASDAQ:DNLI)Holding Weight: 2.64%Prothena(NASDAQ:PRTA)Holding Weight: 2.42%Krystal Biotech(NASDAQ:KRYS)Holding Weight: 2.39%Axsome Therapeutics(NASDAQ:AXSM)Holding Weight: 2.36%Immunocore(NASDAQ:IMCR)Holding Weight: 2.29%SBIO Sector ExposureSBIO Industry ExposureFull Holdings Details Similar ETFsSimplify Propel Opportunities ETFNYSEARCA:SURISimplify Health Care ETFNYSEARCA:PINKProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBProShares Ultra Health CareNYSEARCA:RXLSPDR S&P Health Care Services ETFNYSEARCA:XHSInstitutional OwnershipVirtu Financial LLCBought 15,725 shares on 2/26/2024Ownership: 0.453%Comerica BankSold 1,354 shares on 2/15/2024Ownership: 0.023%Royal Bank of CanadaSold 13,290 shares on 2/14/2024Ownership: 0.447%Kestra Advisory Services LLCBought 500 shares on 2/14/2024Ownership: 0.423%UBS Group AGSold 717 shares on 2/9/2024Ownership: 2.242%View All Institutional Transactions SBIO ETF - Frequently Asked Questions How have SBIO shares performed in 2024? ALPS Medical Breakthroughs ETF's stock was trading at $32.94 on January 1st, 2024. Since then, SBIO stock has increased by 4.6% and is now trading at $34.47. View the best growth stocks for 2024 here. What does SBIO invest in? ALPS Medical Breakthroughs ETF is a equity fund issued by ALPS. SBIO focuses on health care investments and follows the S-Network Medical Breakthroughs Index. The fund's investments total to approximately $114.76 million assets under management. What stocks does ALPS Medical Breakthroughs ETF hold? SBIO invests in 98 holdings. Some of the stocks in their portfolio include Alkermes (ALKS), Cerevel Therapeutics (CERE), ACADIA Pharmaceuticals (ACAD), Vaxcyte (PCVX), Amicus Therapeutics (FOLD), Denali Therapeutics (DNLI), Prothena (PRTA), Krystal Biotech (KRYS), Axsome Therapeutics (AXSM) and Immunocore (IMCR). What is the management fee for ALPS Medical Breakthroughs ETF? ALPS Medical Breakthroughs ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SBIO is 0.50%. What other stocks do shareholders of ALPS Medical Breakthroughs ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX). Who are ALPS Medical Breakthroughs ETF's major shareholders? ALPS Medical Breakthroughs ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include UBS Group AG (2.24%), NTV Asset Management LLC (0.94%), Strategic Financial Services Inc (0.57%), Virtu Financial LLC (0.45%), Royal Bank of Canada (0.45%) and Kestra Advisory Services LLC (0.42%). How do I buy shares of ALPS Medical Breakthroughs ETF? Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:SBIO) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.